NEOG
Neogen Corporation
Price Chart
Latest Quote
$8.83
-0.09 (-1.01%)
Current Price
| Previous Close | $8.92 |
| Open | $8.86 |
| Day High | $9.06 |
| Day Low | $8.79 |
| Volume | 1,871,888 |
Stock Information
| Shares Outstanding | 217.67M |
| Total Debt | $795.10M |
| Cash Equivalents | $159.90M |
| Revenue | $870.56M |
| Net Income | $-608.84M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $1.92B |
| EPS (TTM) | $-2.80 |
| Exchange | NMS |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $2.56B |
| Sales | $870.56M |
| Income | $-608.84M |
| Book/sh | $9.66 |
| Cash/sh | $0.73 |
| Employees | 3K |
Financial Ratios
| Quick Ratio | 1.97 |
| Current Ratio | 3.92 |
| Debt/Eq | 37.82 |
Returns & Margins
| ROA | -0.61% |
| ROE | -25.57% |
| Gross Margin | 45.21% |
| Operating Margin | -1.56% |
| Profit Margin | -69.94% |
Ownership
| Insider Ownership | 0.95% |
| Institutional Ownership | 112.94% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 29.43 |
| PEG | 0.66 |
| P/S | 2.21 |
| P/B | 0.91 |
Analyst Data
| Recommendation | none |
| Target Price | $12.00 |
Technical Indicators
| SMA20 | $9.08 |
| SMA50 | $9.09 |
| SMA200 | $8.13 |
| RSI | 51.44 |
| ATR | 0.3464 |
| Shares Float | 216.29M |
| Short Float | 8.00% |
| Short Ratio | 4.97 |
| Volatility | 1.80 |
| Rel Volume | 1.15 |
Performance History
| Week | -5.05% |
| Month | -0.34% |
| Quarter | -0.11% |
| 6 Months | +18.21% |
| YTD | +26.14% |
| Year | +78.74% |
| 3 Years | -55.43% |
| 5 Years | -80.65% |
| 10 Years | -54.85% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-23 | $8.83 | 2,757,100 |
| 2026-06-22 | $8.92 | 1,233,500 |
| 2026-06-18 | $9.31 | 5,065,600 |
| 2026-06-17 | $8.93 | 1,520,300 |
| 2026-06-16 | $9.31 | 1,745,600 |
| 2026-06-15 | $9.30 | 1,241,900 |
| 2026-06-12 | $9.10 | 1,303,000 |
| 2026-06-11 | $9.25 | 1,150,500 |
| 2026-06-10 | $9.17 | 1,949,600 |
| 2026-06-09 | $9.29 | 1,814,600 |
| 2026-06-08 | $9.07 | 1,631,200 |
| 2026-06-05 | $8.90 | 1,495,500 |
| 2026-06-04 | $9.12 | 1,887,700 |
| 2026-06-03 | $8.81 | 2,014,400 |
| 2026-06-02 | $8.75 | 3,375,000 |
| 2026-06-01 | $8.92 | 2,807,100 |
| 2026-05-29 | $8.97 | 4,429,500 |
| 2026-05-28 | $9.30 | 2,987,900 |
| 2026-05-27 | $9.20 | 3,923,500 |
| 2026-05-26 | $9.14 | 3,438,400 |
About Neogen Corporation
Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and complementary products to detect dangerous and unintended substances in human food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns, as well as food quality and nutritional components. It also provides software systems that help testers analyze and store results; natural toxin tests; rapid sanitation tests; culture and prepared media products; filter tests for microbial analysis of water; sample collection products; and food safety analysis laboratory services. This segment sells its products to the milling and grain, meat and poultry, ready-to-eat, fruits and vegetables, seafood, dairy, beverage, water, healthcare, traditional culture media markets, food service, and dietary supplements markets. Its Animal Safety segment provides reagents and test kits for use in immunoassay production, forensic and animal toxicology, and life science research, as well as colorimetric and chemiluminescent substrates; veterinary instruments and disposables; animal care and other products, including digestive aids and nutritional supplements; rodent and insect control products, and disinfectants; and genomics services, such as DNA genotyping, sequencing, and trait analysis for livestock and companion animals. This segment sells its products to companion animal veterinarians; livestock producers, veterinarians, and breed associations; retailers; breeding and genetics companies; diagnostic labs and universities; distributors; and other manufacturers and government agencies. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.
đ° Latest News
3 Unprofitable Stocks with Questionable Fundamentals
StockStory âĸ 2026-06-19T13:24:58Z
How Investors Are Reacting To Neogen (NEOG) Petrifilm Shift and Operational Efficiency Push
Simply Wall St. âĸ 2026-06-04T06:11:20Z
Neogen (NEOG) Q3 2026 Earnings Transcript
Motley Fool âĸ 2026-06-02T15:48:52Z
3 Healthcare Stocks We Approach with Caution
StockStory âĸ 2026-05-29T17:28:38Z
Q1 Rundown: Neogen (NASDAQ:NEOG) Vs Other Medical Devices & Supplies - Diversified Stocks
StockStory âĸ 2026-05-28T19:02:27Z
Can Neogen Corporation (NEOG) Become One of the Marketâs Best Small-Cap Turnarounds?
Insider Monkey âĸ 2026-05-13T09:00:44Z
Is Weaker Sales And Returns Reshaping The Investment Case For Neogenâs (NEOG) Valuation Assumptions?
Simply Wall St. âĸ 2026-05-05T13:21:09Z
1 of Wall Streetâs Favorite Stock to Target This Week and 2 Facing Challenges
StockStory âĸ 2026-05-02T16:36:55Z
3 Reasons NEOG is Risky and 1 Stock to Buy Instead
StockStory âĸ 2026-04-29T03:08:55Z
5 Must-Read Analyst Questions From Neogenâs Q1 Earnings Call
StockStory âĸ 2026-04-16T11:30:27Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-05-31 | 2024-05-31 | 2023-05-31 | 2022-05-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $473,285,000 | $460,322,000 | $416,492,000 | $284,146,000 |
| Cost Of Revenue | $473,285,000 | $460,322,000 | $416,492,000 | $284,146,000 |
| Total Revenue | $894,661,000 | $924,222,000 | $822,447,000 | $527,159,000 |
| Operating Revenue | $894,661,000 | $924,222,000 | $822,447,000 | $527,159,000 |
| Expenses | ||||
| Interest Expense | $71,622,000 | $73,394,000 | $55,961,000 | $72,000 |
| Total Expenses | $896,337,000 | $865,559,000 | $784,932,000 | $468,541,000 |
| Other Income Expense | $-3,601,000 | $-5,936,000 | $-6,762,000 | $322,000 |
| Other Non Operating Income Expenses | $1,055,720,000 | $-5,936,000 | $-6,762,000 | $322,000 |
| Net Non Operating Interest Income Expense | $-68,512,000 | $-67,032,000 | $-52,795,000 | $1,267,000 |
| Interest Expense Non Operating | $71,622,000 | $73,394,000 | $55,961,000 | $72,000 |
| Operating Expense | $423,052,000 | $405,237,000 | $368,440,000 | $184,395,000 |
| Selling And Marketing Expense | $183,798,000 | $182,872,000 | $141,222,000 | $84,604,000 |
| General And Administrative Expense | $218,167,000 | $199,889,000 | $201,179,000 | $82,742,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-1,092,044,000 | $-9,421,000 | $-22,870,000 | $48,307,000 |
| Net Interest Income | $-68,512,000 | $-67,032,000 | $-52,795,000 | $1,267,000 |
| Interest Income | $3,110,000 | $6,362,000 | $3,166,000 | $1,339,000 |
| Normalized Income | $-71,114,750 | $-9,421,000 | $-22,870,000 | $48,307,000 |
| Net Income From Continuing And Discontinued Operation | $-1,092,044,000 | $-9,421,000 | $-22,870,000 | $48,307,000 |
| Total Operating Income As Reported | $-1,060,997,000 | $58,663,000 | $37,515,000 | $58,618,000 |
| Net Income Common Stockholders | $-1,092,044,000 | $-9,421,000 | $-22,870,000 | $48,307,000 |
| Net Income | $-1,092,044,000 | $-9,421,000 | $-22,870,000 | $48,307,000 |
| Net Income Including Noncontrolling Interests | $-1,092,044,000 | $-9,421,000 | $-22,870,000 | $48,307,000 |
| Net Income Continuous Operations | $-1,092,044,000 | $-9,421,000 | $-22,870,000 | $48,307,000 |
| Pretax Income | $-1,133,110,000 | $-14,305,000 | $-22,042,000 | $60,207,000 |
| Special Income Charges | $-1,059,321,000 | $0 | $0 | - |
| Interest Income Non Operating | $3,110,000 | $6,362,000 | $3,166,000 | $1,339,000 |
| Operating Income | $-1,676,000 | $58,663,000 | $37,515,000 | $58,618,000 |
| Gross Profit | $421,376,000 | $463,900,000 | $405,955,000 | $243,013,000 |
| Per Share | ||||
| Diluted EPS | $-5.03 | $-0.04 | $-0.12 | $0.45 |
| Basic EPS | $-5.03 | $-0.04 | $-0.11 | $0.45 |
| Other | ||||
| Tax Effect Of Unusual Items | $-38,391,750 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $123,505,000 | $180,316,000 | $124,393,000 | $84,411,000 |
| Total Unusual Items | $-1,059,321,000 | $0 | $0 | - |
| Total Unusual Items Excluding Goodwill | $-1,059,321,000 | $0 | $0 | - |
| Reconciled Depreciation | $125,672,000 | $121,227,000 | $90,474,000 | $24,132,000 |
| EBITDA (Bullshit earnings) | $-935,816,000 | $180,316,000 | $124,393,000 | $84,411,000 |
| EBIT | $-1,061,488,000 | $59,089,000 | $33,919,000 | $60,279,000 |
| Diluted Average Shares | $217,044,498 | $216,614,407 | $216,245,501 | $108,020,000 |
| Basic Average Shares | $217,044,498 | $216,614,407 | $216,245,501 | $107,801,094 |
| Diluted NI Availto Com Stockholders | $-1,092,044,000 | $-9,421,000 | $-22,870,000 | $48,307,000 |
| Tax Provision | $-41,066,000 | $-4,884,000 | $828,000 | $11,900,000 |
| Impairment Of Capital Assets | $1,059,321,000 | $0 | $0 | - |
| Research And Development | $21,087,000 | $22,476,000 | $26,039,000 | $17,049,000 |
| Selling General And Administration | $401,965,000 | $382,761,000 | $342,401,000 | $167,346,000 |
| Other Gand A | $218,167,000 | $199,889,000 | $201,179,000 | $82,742,000 |
Fetched: 2026-06-22
Balance Sheet (Annual)
| Metric | 2025-05-31 | 2024-05-31 | 2023-05-31 | 2022-05-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-404,133,000 | $-503,143,000 | $-608,381,000 | $637,167,000 |
| Total Assets | $3,443,836,000 | $4,548,833,000 | $4,554,432,000 | $992,929,000 |
| Total Non Current Assets | $2,866,899,000 | $3,959,600,000 | $3,968,500,000 | $366,131,000 |
| Other Non Current Assets | $35,229,000 | $20,426,000 | $15,220,000 | $2,156,000 |
| Goodwill And Other Intangible Assets | $2,475,387,000 | $3,647,285,000 | $3,742,598,000 | $250,207,000 |
| Other Intangible Assets | $1,410,485,000 | $1,511,653,000 | $1,605,102,000 | $107,503,000 |
| Current Assets | $576,937,000 | $589,233,000 | $585,931,000 | $626,798,000 |
| Other Current Assets | $53,288,000 | $56,025,000 | $53,297,000 | $23,760,000 |
| Assets Held For Sale Current | $50,402,000 | $0 | - | - |
| Inventory | $190,859,000 | $189,267,000 | $133,812,000 | $122,313,000 |
| Receivables | $153,384,000 | $173,005,000 | $153,253,000 | $99,674,000 |
| Accounts Receivable | $153,384,000 | $173,005,000 | $153,253,000 | $99,674,000 |
| Allowance For Doubtful Accounts Receivable | $-5,397,000 | $-4,140,000 | $-2,827,000 | $-1,650,000 |
| Gross Accounts Receivable | $158,781,000 | $177,145,000 | $156,080,000 | $101,324,000 |
| Cash Cash Equivalents And Short Term Investments | $129,004,000 | $170,936,000 | $245,569,000 | $381,051,000 |
| Cash And Cash Equivalents | $129,004,000 | $170,611,000 | $163,240,000 | $44,473,000 |
| Prepaid Assets | - | - | - | $23,760,000 |
| Debt | ||||
| Net Debt | $765,107,000 | $720,227,000 | $722,199,000 | - |
| Total Debt | $894,111,000 | $890,838,000 | $885,439,000 | - |
| Long Term Debt And Capital Lease Obligation | $874,810,000 | $888,391,000 | $885,439,000 | - |
| Long Term Debt | $874,810,000 | $888,391,000 | $885,439,000 | - |
| Current Debt And Capital Lease Obligation | $19,301,000 | $2,447,000 | - | - |
| Current Debt | $19,301,000 | $2,447,000 | - | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $1,372,582,000 | $1,404,691,000 | $1,420,215,000 | $105,555,000 |
| Total Non Current Liabilities Net Minority Interest | $1,198,571,000 | $1,250,368,000 | $1,274,743,000 | $27,711,000 |
| Other Non Current Liabilities | $42,854,000 | $35,259,000 | $35,877,000 | $10,700,000 |
| Non Current Deferred Liabilities | $280,907,000 | $326,718,000 | $353,427,000 | $17,011,000 |
| Non Current Deferred Taxes Liabilities | $280,907,000 | $326,718,000 | $353,427,000 | $17,011,000 |
| Current Liabilities | $174,011,000 | $154,323,000 | $145,472,000 | $77,844,000 |
| Other Current Liabilities | $38,736,000 | $22,800,000 | $20,934,000 | - |
| Current Deferred Liabilities | $5,558,000 | $4,632,000 | $4,616,000 | $5,460,000 |
| Payables And Accrued Expenses | $96,282,000 | $104,495,000 | $94,769,000 | $61,261,000 |
| Interest Payable | $11,078,000 | $10,985,000 | $11,149,000 | $0 |
| Payables | $85,204,000 | $93,510,000 | $83,620,000 | $36,740,000 |
| Total Tax Payable | $5,599,000 | $10,449,000 | $6,951,000 | $2,126,000 |
| Income Tax Payable | $5,599,000 | $10,449,000 | $6,951,000 | $2,126,000 |
| Accounts Payable | $79,605,000 | $83,061,000 | $76,669,000 | $34,614,000 |
| Equity | ||||
| Common Stock Equity | $2,071,254,000 | $3,144,142,000 | $3,134,217,000 | $887,374,000 |
| Total Equity Gross Minority Interest | $2,071,254,000 | $3,144,142,000 | $3,134,217,000 | $887,374,000 |
| Stockholders Equity | $2,071,254,000 | $3,144,142,000 | $3,134,217,000 | $887,374,000 |
| Gains Losses Not Affecting Retained Earnings | $-28,898,000 | $-30,021,000 | $-33,251,000 | $-27,769,000 |
| Other Equity Adjustments | $-28,898,000 | $-30,021,000 | $-33,251,000 | $-27,769,000 |
| Retained Earnings | $-536,424,000 | $555,620,000 | $565,041,000 | $587,911,000 |
| Other | ||||
| Ordinary Shares Number | $217,044,498 | $216,614,407 | $216,245,501 | $107,801,094 |
| Share Issued | $217,044,498 | $216,614,407 | $216,245,501 | $107,801,094 |
| Tangible Book Value | $-404,133,000 | $-503,143,000 | $-608,381,000 | $637,167,000 |
| Invested Capital | $2,965,365,000 | $4,034,980,000 | $4,019,656,000 | $887,374,000 |
| Working Capital | $402,926,000 | $434,910,000 | $440,459,000 | $548,954,000 |
| Total Capitalization | $2,946,064,000 | $4,032,533,000 | $4,019,656,000 | $887,374,000 |
| Additional Paid In Capital | $2,601,848,000 | $2,583,885,000 | $2,567,828,000 | $309,984,000 |
| Capital Stock | $34,728,000 | $34,658,000 | $34,599,000 | $17,248,000 |
| Common Stock | $34,728,000 | $34,658,000 | $34,599,000 | $17,248,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Current Deferred Revenue | $5,558,000 | $4,632,000 | $4,616,000 | $5,460,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $14,134,000 | $19,949,000 | $25,153,000 | $11,123,000 |
| Current Accrued Expenses | $11,078,000 | $10,985,000 | $11,149,000 | $24,521,000 |
| Goodwill | $1,064,902,000 | $2,135,632,000 | $2,137,496,000 | $142,704,000 |
| Net PPE | $356,283,000 | $291,889,000 | $210,682,000 | $113,768,000 |
| Accumulated Depreciation | $-155,431,000 | $-140,288,000 | $-120,118,000 | $-104,875,000 |
| Gross PPE | $511,714,000 | $432,177,000 | $330,800,000 | $218,643,000 |
| Construction In Progress | $186,242,000 | $113,968,000 | $52,237,000 | $5,974,000 |
| Other Properties | $17,152,000 | $14,785,000 | $11,933,000 | $3,184,000 |
| Machinery Furniture Equipment | $188,783,000 | $184,629,000 | $159,627,000 | $120,487,000 |
| Buildings And Improvements | $108,721,000 | $108,298,000 | $96,794,000 | $79,513,000 |
| Land And Improvements | $10,816,000 | $10,497,000 | $10,209,000 | $9,485,000 |
| Properties | $0 | $0 | $0 | $0 |
| Inventories Adjustments Allowances | $-16,483,000 | $-12,361,000 | $-6,270,000 | - |
| Finished Goods | $130,417,000 | $111,839,000 | $68,099,000 | $57,258,000 |
| Work In Process | $11,233,000 | $10,990,000 | $5,366,000 | $6,388,000 |
| Raw Materials | $65,692,000 | $78,799,000 | $66,617,000 | $58,667,000 |
| Other Short Term Investments | $0 | $325,000 | $82,329,000 | $336,578,000 |
| Capital Lease Obligations | - | $0 | $0 | - |
| Long Term Capital Lease Obligation | - | $0 | - | - |
| Current Capital Lease Obligation | - | $2,447,000 | $0 | - |
Fetched: 2026-06-22
Cash Flow Statement (Annual)
| Metric | 2025-05-31 | 2024-05-31 | 2023-05-31 | 2022-05-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-46,351,000 | $-76,157,000 | $-24,729,000 | $43,609,000 |
| Operating Activities | ||||
| Operating Cash Flow | $58,244,000 | $35,264,000 | $41,028,000 | $68,038,000 |
| Cash Flow From Continuing Operating Activities | $58,244,000 | $35,264,000 | $41,028,000 | $68,038,000 |
| Operating Gains Losses | $1,913,000 | $1,073,000 | $-486,000 | - |
| Investing Activities | ||||
| Capital Expenditure | $-104,595,000 | $-111,421,000 | $-65,757,000 | $-24,429,000 |
| Investing Cash Flow | $-99,195,000 | $-29,309,000 | $201,039,000 | $-97,229,000 |
| Cash Flow From Continuing Investing Activities | $-99,195,000 | $-29,309,000 | $201,039,000 | $-97,229,000 |
| Financing Activities | ||||
| Financing Cash Flow | $-1,598,000 | $1,918,000 | $-118,081,000 | $6,813,000 |
| Cash Flow From Continuing Financing Activities | $-1,598,000 | $1,918,000 | $-118,081,000 | $6,813,000 |
| Net Other Financing Charges | $-3,519,000 | $-118,000 | $-19,276,000 | $-1,120,000 |
| Repurchase Of Capital Stock | - | - | - | - |
| Net Common Stock Issuance | - | - | - | - |
| Other | ||||
| Repayment Of Debt | $-550,321,000 | $-420,000 | $-100,000,000 | $0 |
| Issuance Of Debt | $550,000,000 | $0 | $0 | - |
| Interest Paid Supplemental Data | $68,142,000 | $73,168,000 | $42,616,000 | $72,000 |
| Income Tax Paid Supplemental Data | $26,544,000 | $22,303,000 | $15,473,000 | $17,242,000 |
| End Cash Position | $129,004,000 | $170,611,000 | $163,240,000 | $44,473,000 |
| Beginning Cash Position | $170,611,000 | $163,240,000 | $44,473,000 | $75,602,000 |
| Effect Of Exchange Rate Changes | $942,000 | $-502,000 | $-5,219,000 | $-8,751,000 |
| Changes In Cash | $-42,549,000 | $7,873,000 | $123,986,000 | $-22,378,000 |
| Proceeds From Stock Option Exercised | $2,242,000 | $2,456,000 | $1,195,000 | $7,933,000 |
| Net Issuance Payments Of Debt | $-321,000 | $-420,000 | $-100,000,000 | $0 |
| Net Long Term Debt Issuance | $-321,000 | $-420,000 | $-100,000,000 | $0 |
| Long Term Debt Payments | $-550,321,000 | $-420,000 | $-100,000,000 | $0 |
| Long Term Debt Issuance | $550,000,000 | $0 | $0 | - |
| Net Investment Purchase And Sale | $325,000 | $82,004,000 | $254,249,000 | $-34,055,000 |
| Sale Of Investment | $325,000 | $82,004,000 | $266,772,000 | $381,839,000 |
| Purchase Of Investment | $0 | $0 | $-12,523,000 | $-415,894,000 |
| Net Business Purchase And Sale | $0 | $0 | $11,721,000 | $-38,745,000 |
| Sale Of Business | $0 | $0 | $11,721,000 | - |
| Net PPE Purchase And Sale | $-99,520,000 | $-111,313,000 | $-64,931,000 | $-24,429,000 |
| Sale Of PPE | $5,075,000 | $108,000 | $826,000 | $0 |
| Purchase Of PPE | $-104,595,000 | $-111,421,000 | $-65,757,000 | $-24,429,000 |
| Change In Working Capital | $-5,932,000 | $-72,683,000 | $-24,197,000 | $-4,421,000 |
| Change In Other Working Capital | $360,000 | $-21,333,000 | $154,000 | $8,265,000 |
| Change In Payables And Accrued Expense | $-309,000 | $13,587,000 | $22,694,000 | $20,238,000 |
| Change In Accrued Expense | $93,000 | $-164,000 | $4,052,000 | $0 |
| Change In Interest Payable | $93,000 | $-164,000 | $4,052,000 | $0 |
| Change In Payable | $-402,000 | $13,751,000 | $18,642,000 | $20,238,000 |
| Change In Account Payable | $-402,000 | $13,751,000 | $18,642,000 | $20,238,000 |
| Change In Prepaid Assets | $-1,504,000 | $11,113,000 | $-3,121,000 | $-4,054,000 |
| Change In Inventory | $-16,117,000 | $-55,949,000 | $9,955,000 | $-21,072,000 |
| Change In Receivables | $11,638,000 | $-20,101,000 | $-53,879,000 | $-7,798,000 |
| Changes In Account Receivables | $11,638,000 | $-20,101,000 | $-53,879,000 | $-7,798,000 |
| Other Non Cash Items | $380,000 | $8,723,000 | $7,160,000 | $-2,439,000 |
| Stock Based Compensation | $17,291,000 | $13,768,000 | $10,177,000 | $7,154,000 |
| Asset Impairment Charge | $1,068,747,000 | $0 | $0 | $0 |
| Deferred Tax | $-57,783,000 | $-27,423,000 | $-19,230,000 | $-4,695,000 |
| Deferred Income Tax | $-57,783,000 | $-27,423,000 | $-19,230,000 | $-4,695,000 |
| Depreciation Amortization Depletion | $125,672,000 | $121,227,000 | $90,474,000 | $24,132,000 |
| Depreciation And Amortization | $125,672,000 | $121,227,000 | $90,474,000 | $24,132,000 |
| Depreciation | $125,672,000 | $121,227,000 | $90,474,000 | $24,132,000 |
| Gain Loss On Sale Of PPE | $-25,000 | $1,073,000 | $-486,000 | $0 |
| Net Income From Continuing Operations | $-1,092,044,000 | $-9,421,000 | $-22,870,000 | $48,307,000 |
| Purchase Of Business | - | - | - | $-38,745,000 |
| Common Stock Payments | - | - | - | - |
Fetched: 2026-06-22